Home/Filings/4/0001079973-08-001164
4//SEC Filing

HEPLER DOUGLAS I 4

Accession 0001079973-08-001164

CIK 0001167419other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 5:59 PM ET

Size

17.0 KB

Accession

0001079973-08-001164

Insider Transaction Report

Form 4
Period: 2008-12-22
Transactions
  • Sale

    Common Stock

    2008-12-22$5.58/sh2,500$13,95060,000 total(indirect: By Spouse)
  • Sale

    Common Stock

    2008-12-23$5.53/sh2,500$13,82555,000 total(indirect: By Spouse)
Holdings
  • Stock Options

    Exercise: $1.50From: 2004-03-15Exp: 2014-03-15Common Stock (100,000 underlying)
    100,000
  • Common Stock

    5,000
  • Stock Options

    Exercise: $0.80From: 2005-03-28Exp: 2015-03-28Common Stock (50,000 underlying)
    50,000
  • Stock Options

    (indirect: By Spouse)
    Exercise: $0.75From: 2004-08-24Exp: 2014-08-23Common Stock (50,000 underlying)
    50,000
Footnotes (4)
  • [F1]Dr. Hepler disclaims beneficial ownership of the shares held by his spouse
  • [F2]Options vest over three years, at the rate of 33.3% on 4/18/2006, 66.7% on 4/18/2007, and 100% on 4/18/2008. This stock option grant is exempt from Section 16(b) pursuant to Rule 16b-3d.
  • [F3]Options were granted pursuant to Board approval on January 24, 2007. The aggregate number of stock options granted was 50,000. One-third (16,666) of the options vest each year for three years following the date of grant. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F4]Options were granted pursuant to Board approval on January 17, 2008. The aggregate number of stock options granted was 50,000. One third (16,666) of the options vest each year for three years following the date of grant. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).

Issuer

AspenBio Pharma, Inc.

CIK 0001167419

Entity typeother

Related Parties

1
  • filerCIK 0001287149

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:59 PM ET
Size
17.0 KB